These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
128 related items for PubMed ID: 32709802
21. Intravitreal topotecan in the management of refractory and recurrent vitreous seeds in retinoblastoma. Rao R, Honavar SG, Sharma V, Reddy VAP. Br J Ophthalmol; 2018 Apr; 102(4):490-495. PubMed ID: 28844050 [Abstract] [Full Text] [Related]
22. Evolution of Chemotherapy Approaches for the Treatment of Intraocular Retinoblastoma: A Comprehensive Review. Yuan S, Friedman DL, Daniels AB. Int Ophthalmol Clin; 2017 Apr; 57(1):117-128. PubMed ID: 27898618 [No Abstract] [Full Text] [Related]
30. Diffuse chorioretinal atrophy after a single standard low- dose intravitreal melphalan injection in a child with retinoblastoma: a case report. Chao A, Kao LY, Liu L, Wang NK. BMC Ophthalmol; 2016 Mar 15; 16():27. PubMed ID: 26975871 [Abstract] [Full Text] [Related]
32. Topotecan combination chemotherapy in two new rodent models of retinoblastoma. Laurie NA, Gray JK, Zhang J, Leggas M, Relling M, Egorin M, Stewart C, Dyer MA. Clin Cancer Res; 2005 Oct 15; 11(20):7569-78. PubMed ID: 16243833 [Abstract] [Full Text] [Related]
33. Retinoblastoma: evidence for stage-based chemotherapy. Chung CY, Medina CA, Aziz HA, Singh AD. Int Ophthalmol Clin; 2015 Oct 15; 55(1):63-75. PubMed ID: 25436494 [No Abstract] [Full Text] [Related]
34. Combined intravitreal melphalan and intravenous/intra-arterial chemotherapy for retinoblastoma with vitreous seeds. Lee JH, Han JW, Hahn SM, Lyu CJ, Kim DJ, Lee SC. Graefes Arch Clin Exp Ophthalmol; 2016 Feb 15; 254(2):391-4. PubMed ID: 26511530 [Abstract] [Full Text] [Related]
35. Pharmacokinetic analysis of topotecan after intra-vitreal injection. Implications for retinoblastoma treatment. Buitrago E, Höcht C, Chantada G, Fandiño A, Navo E, Abramson DH, Schaiquevich P, Bramuglia GF. Exp Eye Res; 2010 Jul 15; 91(1):9-14. PubMed ID: 20307538 [Abstract] [Full Text] [Related]
36. Retinoblastoma: direct chemotherapeutic drug delivery into the vitreous cavity. Seregard S, Singh AD. Br J Ophthalmol; 2012 Apr 15; 96(4):473-4. PubMed ID: 22421997 [No Abstract] [Full Text] [Related]
38. Chemoreduction of Progressive Intraocular Retinoblastoma by Systemic Topotecan. Sultan I, Hajja Y, Nawaiseh I, Mehyar M, Deebajah R, Jaradat I, Yousef YA. Ophthalmic Genet; 2016 Jun 15; 37(2):209-13. PubMed ID: 26760494 [Abstract] [Full Text] [Related]
39. Not All Seeds Are Created Equal: Seed Classification Is Predictive of Outcomes in Retinoblastoma. Berry JL, Bechtold M, Shah S, Zolfaghari E, Reid M, Jubran R, Kim JW. Ophthalmology; 2017 Dec 15; 124(12):1817-1825. PubMed ID: 28655537 [Abstract] [Full Text] [Related]
40. Stability of melphalan solution for intravitreal injection for retinoblastoma. Buitrago E, Lagomarsino E, Mato G, Schaiquevich P. JAMA Ophthalmol; 2014 Nov 15; 132(11):1372-3. PubMed ID: 25078631 [No Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]